Comparator choices in pharmacoepidemiology studies of Alzheimer's disease

被引:2
|
作者
Her, Qoua. L. [1 ]
Kahrs, Jacob. C. [1 ]
Sturmer, Til [1 ]
机构
[1] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA
来源
NATURE AGING | 2023年 / 3卷 / 07期
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s43587-023-00417-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:791 / 792
页数:2
相关论文
共 50 条
  • [1] Comparator choices in pharmacoepidemiology studies of Alzheimer’s disease
    Qoua L. Her
    Jacob C. Kahrs
    Til Stürmer
    [J]. Nature Aging, 2023, 3 : 791 - 792
  • [2] Reply to: Comparator choices in pharmacoepidemiology studies of Alzheimer's disease
    Zhang, Pengyue
    Hou, Yuan
    Chiang, Chien-Wei
    Pieper, Andrew A.
    Cummings, Jeffrey
    Cheng, Feixiong
    [J]. NATURE AGING, 2023, 3 (07): : 793 - 795
  • [3] Reply to: Comparator choices in pharmacoepidemiology studies of Alzheimer’s disease
    Pengyue Zhang
    Yuan Hou
    Chien-Wei Chiang
    Andrew A. Pieper
    Jeffrey Cummings
    Feixiong Cheng
    [J]. Nature Aging, 2023, 3 : 793 - 795
  • [4] Memory for choices in Alzheimer's disease
    Budson, Andrew E.
    Mather, Mara
    Chong, Hyemi
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2006, 22 (02) : 150 - 158
  • [5] RCTS vs observational studies: The only choices in pharmacoepidemiology?
    Sacks, S.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S246 - S246
  • [6] Pharmacoepidemiology evaluation of bumetanide as a potential candidate for drug repurposing for Alzheimer's disease
    Morales, Jasmine
    Gabriel, Nico
    Natarajan, Loki
    LaCroix, Andrea Z.
    Shadyab, Aladdin H.
    Xu, Ronghui
    Silverman, James
    Feldman, Howard H.
    Hernandez, Inmaculada
    [J]. ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5236 - 5246
  • [7] Rationale of Medication Choices in Patients With Alzheimer's Disease
    Wee, Khui Wei
    Tong, Kah Cheong
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2024, 25 (08)
  • [8] Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology
    McMahon, AD
    Evans, JMM
    McGilchrist, MM
    McDevitt, DG
    MacDonald, TM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1998, 7 (04) : 275 - 280
  • [9] Neurochemical studies of Alzheimer's disease
    Palmer, AM
    [J]. NEURODEGENERATION, 1996, 5 (04): : 381 - 391
  • [10] Studies in mild Alzheimer's disease
    不详
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2013, 17 (01) : 31 - 32